10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Dec. 22, 2021 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

10x Genomics' management is scheduled to present virtually on Monday, January 10, at 2:15 p.m. Eastern Time / 11:15 a.m. Pacific Time.  Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company's integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2020 based on publications and all of the top 20 global pharmaceutical companies by 2020 research and development spend, and have been cited in over 3,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 1,200 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Media Contact:
media@10xgenomics.com

Investor Relations Contact:  
investors@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-virtually-at-the-40th-annual-jp-morgan-healthcare-conference-301450093.html

SOURCE 10x Genomics, Inc.